Drug Trials Snapshots: RYTELO
Summary
RYTELO is a prescription medicine used to treat a condition called low- to intermediate-1 risk myelodysplastic syndromes (MDS) in adults with anemia.
Description
RYTELO is a prescription medicine used to treat a condition called low- to intermediate-1 risk myelodysplastic syndromes (MDS) in adults with anemia.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source